Daiichi Sankyo, Inc. et al v. United States Patent and Trademark Office et al
| Daiichi Sankyo, Inc. and Astrazeneca Pharmaceuticals, LP |
| USPTO, Department of Commerce, Andrew Hirshfeld and United States Patent and Trademark Office |
| 1:2021cv00899 |
| August 5, 2021 |
| US District Court for the Eastern District of Virginia |
| John F Anderson |
| Leonie M Brinkema |
| Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision |
| 05 U.S.C. ยง 702 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 11, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 10
Summons Issued as to Andrew Hirshfeld, United States Patent and Trademark Office, U.S. Attorney and U.S. Attorney General (Attachments: #1 Summons, #2 Summons, #3 Summons)(swil)
|
|
Filing 9
Proposed Summons re #5 Amended Complaint, to Office of the General Counsel, United States Patent and Trademark Office by Astrazeneca Pharmaceuticals, LP, Daiichi Sankyo, Inc.. (Pade, Jeffrey)
|
|
Filing 8
Proposed Summons re #5 Amended Complaint, to RAJ PAREKH, Acting United States Attorney for the Eastern District of Virginia by Astrazeneca Pharmaceuticals, LP, Daiichi Sankyo, Inc.. (Pade, Jeffrey)
|
|
Filing 7
Proposed Summons re #5 Amended Complaint, to MERRICK B. GARLAND, Attorney General of the United States by Astrazeneca Pharmaceuticals, LP, Daiichi Sankyo, Inc.. (Pade, Jeffrey)
|
|
Filing 6
Proposed Summons re #5 Amended Complaint, to ANDREW HIRSHFELD, in his official capacity as Performing the Functions and Duties of the Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office by Astrazeneca Pharmaceuticals, LP, Daiichi Sankyo, Inc.. (Pade, Jeffrey)
|
|
Filing 5
AMENDED COMPLAINT against Andrew Hirshfeld, United States Patent and Trademark Office, filed by Daiichi Sankyo, Inc., Astrazeneca Pharmaceuticals, LP. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, #10 Exhibit J)(Pade, Jeffrey)
|
|
Filing 4
Corporate Disclosure Statement by Astrazeneca Pharmaceuticals, LP. (Bennett, Edward)
|
|
Notice of Correction re 3 Corporate Disclosure Statement. The filing user has been notified that document 3 is an incorrectly saved PDF fillable form and has been removed. The filing user was directed to refile the document. (lber)
|
|
Initial Case Assignment to District Judge Leonie M. Brinkema and Magistrate Judge John F. Anderson. (lber)
|
|
Filing 3
REMOVED - Corporate Disclosure Statement by Astrazeneca Pharmaceuticals, LP. (Bennett, Edward) Modified on 8/6/2021 (lber).
|
|
Filing 2
Financial Interest Disclosure Statement (Local Rule 7.1) by Daiichi Sankyo, Inc.. (Pade, Jeffrey)
|
|
Filing 1
Complaint ( Filing fee $ 402, receipt number AVAEDC-7930893.), filed by Daiichi Sankyo, Inc., Astrazeneca Pharmaceuticals, LP. (Attachments: #1 Civil Cover Sheet, #2 Exhibit A, #3 Exhibit B, #4 Exhibit C, #5 Exhibit D, #6 Exhibit E, #7 Exhibit F, #8 Exhibit G)(Pade, Jeffrey)
|
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Virginia Eastern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
